AstraZeneca Hit With New Compliance Mandates In Seroquel Settlement With States
This article was originally published in The Pink Sheet Daily
Executive Summary
A $68.5 million settlement agreement with the states imposes restrictions on physician detailing and the presentation of clinical trial data, among other things.
You may also be interested in...
The Era Of Billion Dollar Pharma Settlements
Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.
AstraZeneca Faces Government Probe Of Synagis Sales And Marketing
The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.
AstraZeneca Faces Government Probe Of Synagis Sales And Marketing
The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.